Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dystrophic epidermolysis bullosa
dystrophic epidermolysis bullosa
Eyedrop Version of Krystal’s Gene Therapy Vyjuvek Restores Sight in Teen
BioSpace
Thu, 02/8/24 - 11:22 am
Krystal Biotech
Vyjuvek
gene therapy
dystrophic epidermolysis bullosa
Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease
Fierce Pharma
Sun, 05/21/23 - 10:48 pm
Krystal Biotech
Vyjuvek
dystrophic epidermolysis bullosa
gene therapy
FDA
Krystal Biotech Submits BLA for Rare Skin Disease Treatment
BioSpace
Wed, 06/22/22 - 06:59 pm
Krystal Biotech
B-VEC
FDA
dystrophic epidermolysis bullosa
Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
CP Wire
Tue, 01/15/19 - 09:59 am
Krystal Biotech
KB103
dystrophic epidermolysis bullosa
Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
Tue, 01/15/19 - 09:51 am
Krystal Biotech
KB103
dystrophic epidermolysis bullosa
Krystal Biotech Doses First Patient in Phase 1/2 trial of KB103 Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa
CP Wire
Sat, 05/12/18 - 01:39 pm
Krystal Biotech
dystrophic epidermolysis bullosa
KB103
Krystal Biotech Doses First Patient in Phase 1/2 trial of KB103 Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa
Fri, 05/11/18 - 09:27 am
Krystal Biotech
dystrophic epidermolysis bullosa
KB103